186 related articles for article (PubMed ID: 34592743)
21. Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma.
Lee KJ; Yi SW; Chung MJ; Park SW; Song SY; Chung JB; Park JY
Yonsei Med J; 2013 May; 54(3):643-9. PubMed ID: 23549809
[TBL] [Abstract][Full Text] [Related]
22. Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer.
Bergman B; Brezicka FT; Engström CP; Larsson S
Eur J Cancer; 1993; 29A(2):198-202. PubMed ID: 8380696
[TBL] [Abstract][Full Text] [Related]
23. The combination of pretreatment prognostic nutritional index and neuron-specific enolase enhances prognosis predicting value of small cell lung cancer.
Wang C; Jin S; Xu S; Cao S
Clin Respir J; 2021 Mar; 15(3):264-271. PubMed ID: 33058444
[TBL] [Abstract][Full Text] [Related]
24. [Significance of serum neuron-specific enolase before treatment in predicting brain metastases and prognosis of advanced non-small cell lung cancer].
Chen Y; Peng W; Huang Y; Chen J; Su G; Jiang C; Xiao Y
Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):508-11. PubMed ID: 26463326
[TBL] [Abstract][Full Text] [Related]
25. Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer.
Dong Y; Zheng X; Yang Z; Sun M; Zhang G; An X; Pan L; Zhang S
J Cancer Res Ther; 2016 Oct; 12(Supplement):34-36. PubMed ID: 27721249
[TBL] [Abstract][Full Text] [Related]
26. Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis.
Wang R; Zuo CL; Zhang R; Zhu LM
World J Gastrointest Oncol; 2023 Aug; 15(8):1475-1485. PubMed ID: 37663935
[TBL] [Abstract][Full Text] [Related]
27. Preliminary evaluation of clinical utility of CYFRA 21-1, CA 72-4, NSE, CA19-9 and CEA in stomach cancer.
Gwak HK; Lee JH; Park SG
Asian Pac J Cancer Prev; 2014; 15(12):4933-8. PubMed ID: 24998567
[TBL] [Abstract][Full Text] [Related]
28. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
[TBL] [Abstract][Full Text] [Related]
29. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y
BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431
[TBL] [Abstract][Full Text] [Related]
30. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
[TBL] [Abstract][Full Text] [Related]
31. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
Wang B; He YJ; Tian YX; Yang RN; Zhu YR; Qiu H
Asian Pac J Cancer Prev; 2014; 15(22):9611-4. PubMed ID: 25520076
[TBL] [Abstract][Full Text] [Related]
32. [A clinical evaluation of the versatility of various tumor markers in diagnosing the primary carcinoma of the lung].
Shimabukuro Z
Nihon Ika Daigaku Zasshi; 1989 Jun; 56(3):281-93. PubMed ID: 2546967
[TBL] [Abstract][Full Text] [Related]
33. The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
Kobayashi S; Okada S; Hasumi T; Sato N; Fujimura S
Tohoku J Exp Med; 1999 Sep; 189(1):37-49. PubMed ID: 10622207
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer.
Abbas M; Ahmed A; Khan GJ; Baig MMFA; Naveed M; Mikrani R; Cao T; Naeem S; Shi M; Dingding C
Curr Probl Cancer; 2019 Feb; 43(1):5-17. PubMed ID: 30172422
[TBL] [Abstract][Full Text] [Related]
35. Neuron - specific enolase predicts the prognosis in advanced small cell lung cancer patients treated with first-line PD-1/PD-L1 inhibitors.
Li L; Zhang Z; Hu Y
Medicine (Baltimore); 2021 Sep; 100(36):e27029. PubMed ID: 34516493
[TBL] [Abstract][Full Text] [Related]
36. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
[TBL] [Abstract][Full Text] [Related]
38. Prognostic stratification of pathological node-negative lung adenocarcinoma by carcinoembryonic antigen level.
Batmunkh K; Cho S; Yum S; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2020 Jun; 30(6):820-826. PubMed ID: 32221597
[TBL] [Abstract][Full Text] [Related]
39. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.
Jørgensen LG; Hansen HH; Cooper EH
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):123-8. PubMed ID: 2537729
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer.
Yan P; Han Y; Tong A; Liu J; Wang X; Liu C
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34286335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
